PT Suparma Tbk (IDX:SPMA)

PT Suparma Tbk Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	106,231	104,839	178,658	336,138	294,326
Depreciation & Amortization	125,749	114,630	111,029	104,658	91,289
Other Operating Activities	355,596	491,334	396,981	478,411	406,191
Operating Cash Flow	587,575	710,803	686,668	919,207	791,806
Operating Cash Flow Growth	-17.34%	3.52%	-25.30%	16.09%	13.14%
Capital Expenditures	-44,853	-39,315	-31,718	-57,054	-47,036
Sale of Property, Plant & Equipment	-	-	200	-	-
Sale (Purchase) of Intangibles	-4,288	-2,450	-	-	-
Investment in Securities	-16,294	-10,932	8,174	-11,011	-16,297
Investing Cash Flow	-65,436	-52,697	-23,344	-68,065	-63,332
Long-Term Debt Issued	53,614	-	2,798,384	2,882,500	3,274,695
Total Debt Issued	53,614	-	2,798,384	2,882,500	3,274,695
Short-Term Debt Repaid	-622,992	-620,993	-32,781	-333,696	-349,116
Long-Term Debt Repaid	-34,381	-36,314	-3,415,266	-3,303,707	-3,538,513
Total Debt Repaid	-657,373	-657,307	-3,448,047	-3,637,403	-3,887,629
Net Debt Issued (Repaid)	-603,759	-657,307	-649,663	-754,902	-612,934
Common Dividends Paid	-	-37,760	-	-	-31,633
Financing Cash Flow	-603,759	-695,067	-649,663	-754,902	-644,567
Foreign Exchange Rate Adjustments	1,945	2,719	-1,847	6,411	1,861
Net Cash Flow	-79,675	-34,241	11,813	102,651	85,768
Free Cash Flow	542,722	671,488	654,950	862,153	744,770
Free Cash Flow Growth	-19.18%	2.53%	-24.03%	15.76%	16.35%
Free Cash Flow Margin	19.80%	24.60%	24.64%	27.47%	26.65%
Free Cash Flow Per Share	132.36	163.76	159.73	210.26	181.64
Cash Interest Paid	44,647	39,692	37,617	36,098	33,352
Cash Income Tax Paid	24,245	25,524	48,439	53,389	44,598
Levered Free Cash Flow	15,237	102,537	179,253	141,946	109.56
Unlevered Free Cash Flow	40,224	124,541	201,050	162,372	19,707

Source: S&P Global Market Intelligence. Standard template. Financial Sources.